Back to first-pass browser

First-pass extracted concept

Mesenchymal stromal/stem cells in cancer therapy

Candidate: concept label1 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

MSCs

Extracted Explainers

What the tool is doing

The review describes MSC-based anticancer strategies that use the natural properties of MSCs in targeted therapeutic applications. It frames MSCs as a platform for engineered or biotechnological cancer therapy approaches.

Source 1DOIPubMed

What problem it solves

MSC-based strategies aim to improve targeted delivery or localized therapeutic action in cancer treatment. The abstract presents this as a way to combine MSC properties with anticancer interventions.

Source 1DOIPubMed

What it does not solve

The abstract states that important impediments remain and that MSCs have a bidirectional role in cancer, limiting straightforward clinical use.

Source 1DOIPubMed

Alternatives

The abstract mentions combining MSC-based therapies with therapies already used clinically, but does not specify particular comparator modalities.

Source 1DOIPubMed

Evidence Snippets

This article provides an overview of MSC-based therapeutic strategies, assessing their potential in the context of cancer treatment.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1safety or context dependencesupports2025Source 1DOIPubMed

A major challenge in the clinical application of MSCs is their bidirectional role.

Claim 2scope overviewsupports2025Source 1DOIPubMed

The article provides an overview of MSC-based therapeutic strategies in the context of cancer treatment.

Claim 3translational limitationsupports2025Source 1DOIPubMed

Further studies are required to address existing impediments to MSC-based cancer therapies.